Prostacyclin and endothelium-dependent hyperpolarization

Pharmacological Research

Volumn 49, Issue 6, 2004, Pages 509-514

  Parkington, Helena C ^a   Coleman, Harold A ^a   Tare, Marianne ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Hypoxia; Potassium channels; Pre eclampsia; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; ENDOTHELIUM DERIVED RELAXING FACTOR; EPOXYICOSATRIENOIC ACID; GLIBENCLAMIDE; HYDROXYICOSATETRAENOIC ACID; ILOPROST; INDOMETACIN; PROSTACYCLIN; PROSTANOID; SEX HORMONE;

BLOOD PRESSURE; BLOOD VESSEL; CORONARY BLOOD VESSEL; ENDOTHELIUM; HYPERPOLARIZATION; HYPOXIA; NONHUMAN; OXIDATIVE STRESS; PREGNANCY; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE; THROMBOGENESIS; VASCULARIZATION; VASODILATATION;

EID: 1542407655     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2003.11.012     Document Type: Article

References (61)

1. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
2. Moncada S., Gryglewski R.J., Bunting S., Vane J.R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 263:1976;663-665.
3. 2) by layers of the arterial wall. An explanation for the anti-thrombotic properties of vascular endothelium. Thromb. Res. 11:1977;323-344.
4. Kukovetz W.R., Holzmann S., Wurm A., Pöch G. Prostacyclin increases cAMP in coronary arteries. J. Cyclic Nucleotide Res. 5:1979;469-476.
5. Ignarro L.J., Harbison R.G., Wood K.S., Wolin M.S., McNamara D.B., Hyman A.L.et al. Differences in responsiveness of intrapulmonary artery and vein to arachidonic acid: mechanisms of arterial relaxation involves cyclic guanosine 3′:5′-monophosphate and cyclic adenosine 3′:5′- monophosphate. J. Pharmacol. Exp. Ther. 233:1985;560-569.
6. Siegel G, Stock G, Schnalke F, Litza B. Electrical and mechanical effects of prostacyclin in canine carotid artery. In: Gryglewski RJ, Stock G, editors. Prostacyclin and its stable analogue iloprost. Springer-Verlag, Berlin/Heidelberg; 1987. p. 143-9.
7. Parkington H.C., Tare M., Tonta M.A., Coleman H.A. Stretch revealed three components in the hyperpolarization of guinea-pig coronary artery in response to acetylcholine. J. Physiol. 465:1993;459-476.
8. Parkington H.C., Tonta M.A., Coleman H.A., Tare M. Role of membrane potential in endothelium-dependent relaxation of guinea-pig coronary arterial smooth muscle. J. Physiol. 484:1995;469-480.
9. Ca-channel activation by cAMP-dependent protein kinase. Am. J. Physiol. 272:1997;H1147-H1156.
10. + channels play a major role in mediating the vascular effects of ilopprost and cicaprost. Eur. J. Pharmacol. 356:1998;215-224.
11. Yajima K., Nishiyama M., Yamamoto Y., Suzuki H. Inhibition of endothelium-dependent hyperpolarization by endothelial prostanoids in guinea-pig coronary artery. Br. J. Pharmacol. 126:1999;1-10.
12. Thapaliya S., Matsuyama H., Takewaki T. Bradykinin causes endothelium-independent hyperpolarization and neuromodulation by prostanoid synthesis in hamster mesenteric artery. Eur. J. Pharmacol. 408:2000;313-321.
13. Tare M., Parkington H.C., Coleman H.A. EDHF, NO and a prostanoid: hyperpolarization-dependent and -independent relaxation in guinea-pig arteries. Br. J. Pharmacol. 130:2000;605-618.
14. Corriu C., Félétou M., Edwards G., Weston A.H., Vanhoutte P.M. Differential effects of prostacyclin and iloprost in the isolated carotid artery of the guinea-pig. Eur. J. Pharmacol. 426:2001;89-94.
15. ATP channels. Am. J. Physiol. 273:1997;H2687-H2695.
16. Frisbee J.C., Roman R.J., Krishna U.M., Falck J.R., Lombard J.H. Relative contributions of cyclooxygenase- and cytochrome P450 - hydroxylase-dependent pathways to hypoxic dilation of skeletal muscle resistance arteries. J. Vasc. Res. 38:2001;305-314.
17. Dong H., Waldron G.J., Cole W.C., Triggle C.R. Roles of calcium-activated and voltage-gated delayed rectifier potassium channels in endothelium-dependent vasorelaxation of the rabbit middle cerebral artery. Br. J. Pharmacol. 123:1998;821-832.
18. Grainger J., Boachie-Ansah G. Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels. Br. J. Pharmacol. 134:2001;1003-1012.
19. Zygmunt P.M., Plane F., Paulsson M., Garland C.J., Högestätt E.D. Interactions between endothelium-derived relaxing factors in the rat hepatic artery: focus on regulation of EDHF. Br. J. Pharmacol. 124:1998;992-1000.
20. Jackson W.F., König A., Dambacher T., Busse R. Prostacyclin-induced vasodilation in rabbit heart is mediated by ATP-sensitive potassium channels. Am. J. Physiol. 264:1993;H238-H243.
21. G-Monomethyl-L-arginine does not inhibit the hindquarters vasodilator action of endothelin-1 in conscious rats. Eur. J. Pharmacol. 171:1989;237-240.
22. Vallance P, Collier J, Moncada S. Effect of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;ii:997-1000.
23. Huang P.L., Huang Z., Mashimo H., Block K.D., Moskowitz M.A., Bevan J.A.et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 377:1995;239-242.
24. Duffy S.J., Castle S.F., Harper R.W., Meredith I.T. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation. Circulation. 100:1999;1951-1957.
25. Gardiner S.M., Compton A.M., Bennett T. Effects of indomethacin on the regional haemodynamic responses to low doses of endothelins and sarafotoxin. Br. J. Pharmacol. 100:1990;158-162.
26. Parkington H.C., Chow J.-A.M., Evans R.G., Coleman H.A., Tare M. Role for endothelium-derived hyperpolarizing factor in vascular tone in rat mesenteric and hindlimb circulations in vivo. J. Physiol. 542.3:2002;929-937.
27. Ray C.J., Abbas M.R., Coney A.M., Marshall J.M. Interactions of adenosine, prostaglandins and nitric oxide in hypoxia-induced vasodilatation: in vivo and in vitro studies. J. Physiol. 544:2002;195-209.
28. Lim H., Gupta R.A., Ma W., Paria B.C., Moller D.E., Morrow J.D. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARδ Genes Dev. 13:1999;1561-1574.
29. Iwai N., Katsuya T., Ishikawa K., Mannami T., Ogata J., Higaki J.et al. Human prostacyclin syntase gene and hypertension: the Suita Study. Circulation. 100:1999;2231-2236.
30. Yokoyama C., Yabuki T., Shimonishi M., Wada M., Hatae T., Ohkawara S.et al. Prostacyclin-deficient mice develop ischemic renal disorders, includingnephrosclerosis and renal infarction. Circulation. 106:2002;2397-2403.
31. Caughey G.E., Cleland L.G., Gamble J.R., James M.J. Up-regulation of endothelial cyclooxygenase-2 and prostanoid synthesis by platelets. J. Biol. Chem. 276:2001;37839-37845.
32. Hennan J.K., Huang J., Barrett T.D., Driscoll E.M., Willens D.E., Park A.M.et al. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries. Circulation. 104:2001;820-825.
33. Parfenova H., Levine V., Gunther W.M., Pourcyrous M., Leffler C.W. COX-1 and COX-2 contributions to basal and IL-1β-stimulated prostanoid synthesis in human neonatal cerebral microvascular endothelial cells. Pediatr. Res. 52:2002;342-348.
34. Parfenova H., Massie V., Leffler C.W. Developmental changes in endothelium-derived vasorelaxant factors in cerebral circulation. Am. J. Physiol. 278:2000;H780-H788.
35. McKay M.K., Gardner A.L., Boyd D., Hester R.L. Influence of venular prostaglandin release on arteriolas diameter during functional hyperemia. Hypertension. 31:1998;213-217.
36. 2 and myoendothelial gap junctions in melittin-induced arterial relaxation. Eur. J. Pharmacol. 406:2000;239-245.
37. Griffith T.M., Chaytor A.T., Taylor H.J., Gidding B.D., Edwards D.H. cAMP facilitates EDHF-type relaxations in conduit arteries by enhancing electrotonic conduction via gap junctions. Proc. Natl. Acad. Sci. U.S.A. 99:2002;6392-6397.
38. Sandow S.L., Tare M., Coleman H.A., Hill C.E., Parkington H.C. Involvement of myoendothelial gap junctions in the actions of endothelium-derived hyperpolarizing factor. Circ. Res. 90:2002;1108-1113.
39. 2 balance: pathophysiological and therapeutic implications. Br. Med. Bull. 39:1983;271-276.
40. Adatia I. Recent advances in pulmonary vascular disease. Curr. Opin. Pediatr. 14:2002;292-297.
41. Huang K., Liu H., Chen Z., Xu H. Role of selenium in cytoprotection against cholesterol oxide-induced vascular damage in rats. Atherosclerosis. 162:2002;137-144.
42. Walsh S.W. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am. J. Obstet. Gynecol. 152:1985;335-340.
43. Rowe J., Campbell S., Gallery E.D.M. Effects of hypoxia on regulation of prostanoid production in decidual endothelial cells in normal and preeclamptic pregnancy. J. Soc. Gynecol. Invest. 7:2000;118-124.
44. Frisbee J.C. Impaired dilation of skeletal muscle microvessels to reduced oxygen tension in diabetic obese Zucker rats. Am. J. Physiol. 281:2001;H1568-H1574.
45. 2+ channels. Am. J. Physiol. 283:2002;H247-H253.
46. Bachschmid M., Thurau S., Zou M.H., Ullrich V. Endothelial cell activation by endotoxin involves superoxide/NO-mediated nitration of prostacyclin synthase and thromboxane receptor stimulation. FASEB J. 17:2003;914-916.
47. Ozaki N., Beharry K., Nishihara K.C., Akmal Y., Ang J.G., Modanlou H.D. Differential regulation of prostacyclin and thromboxane by dexamethasone and celecoxib during oxidative stress in newborn rabbits. Prostaglandins Lipid Med. 70:2002;61-78.
48. Bell C. Dual vasoconstrictor and vasodilator innervation of the uterine arterial supply in the guinea-pig. Circ. Res. 23:1968;279-289.
49. Poston L., McCarthy A.L., Ritter J.M. Control of vascular resistance in the maternal and feto-placental arterial beds. Pharmacol Ther. 65:1995;215-239.
50. Gerber R.T., Anwar M.A., Poston L. Enhanced acetylcholine induced relaxation in small mesenteric arteries from pregnant rats: an important role for endothelium-derived hyperpolarizing factor (EDHF). Br. J. Pharmacol. 125:1998;455-460.
51. Kenny L.C., Baker P.N., Kendall D.A., Randall M.D., Dunn W.R. Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and per-eclampsia. Clin. Sci. 103:2002;67-73.
52. Bird I.M., Zhang L., Magness R.R. Possible mechanisms underlying pregnancy-induced changes in uterine artery endothelial function. Am. J. Physiol. 284:2003;R245-R258.
53. Chavarría M.E., Lara-González L., González-Gleason A., García-Paleta Y., Vital-Reyes V.S., Reyes A. Prostacyclin/ thromboxane early changes in pregnancies that are complicated by preeclampsia. Am. J. Obstet. Gynecol. 188:2003;986-992.
54. Brown M.A. The physiology of preeclampsia. Clin. Exp. Pharmacol. Physiol. 22:1995;781-791.
55. Suzuki Y., Hattori T., Kajikuri J., Yamamoto T., Suzumori K. Reduced function of endothelial prostacyclin in human omental resistance arteries in pre-eclampsia. J. Physiol. 545:2002;269-277.
56. Rodriguez G., Warkentin S., Risberg J., Rosadini G. Sex differences in regional cerebral blood flow. J. Cereb. Blood Flow Metab. 8:1988;783-789.
57. Rupnow H.L., Phernetton T.M., Modrick M.L., Wiltbank M.C., Bird I.M., Magness R.R. Endothelial vasodilator production by uterine and systemic arteries. VIII. Estrogen and progesterone effects on cPLA2, COX-1, and PGIS protein expression. Biol. Reprod. 66:2002;468-474.
58. Ospina J.A., Duckles S.P., Krause D.N. 17β-Estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilators. Am. J. Physiol. 285:2003;H241-H250.
59. Andrews T.C., Ballantyne C.M., Hsia J.A., Kramer J.H. Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins. Am. J. Med. 111:2001;185-191.
60. Pravenec M., Kunes J., Zicha J., Kren V., Klir P. Platelet aggregation in spontaneous hypertension: genetic determination and correlation analysis. J. Hypertens. 10:1992;1453-1456.
61. Nomura S., Suzuki M., Katsura K., Xie G.L., Miyazaki Y., Miyake T.et al. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis. 116:1995;235-240.